Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Integrative Bioscience and Biotechnology, Pohang University of Science and Technology, Pohang, Gyeongbuk 37673, Republic of Korea.
Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):507-512. doi: 10.1073/pnas.1719746115. Epub 2018 Jan 2.
HIV-1 reverse transcriptase (RT) contains both DNA polymerase and RNase H activities to convert the viral genomic RNA to dsDNA in infected host cells. Here we report the 2.65-Å resolution structure of HIV-1 RT engaging in cleaving RNA in an RNA/DNA hybrid. A preferred substrate sequence is absolutely required to enable the RNA/DNA hybrid to adopt the distorted conformation needed to interact properly with the RNase H active site in RT. Substituting two nucleotides 4 bp upstream from the cleavage site results in scissile-phosphate displacement by 4 Å. We also have determined the structure of HIV-1 RT complexed with an RNase H-resistant polypurine tract sequence, which adopts a rigid structure and is accommodated outside of the nuclease active site. Based on this newly gained structural information and a virtual drug screen, we have identified an inhibitor specific for the viral RNase H but not for its cellular homologs.
HIV-1 逆转录酶(RT)兼具 DNA 聚合酶和核糖核酸酶 H 的活性,可将病毒基因组 RNA 转化为感染宿主细胞中的双链 DNA。在此,我们报告了 HIV-1 RT 与 RNA/DNA 杂交体结合以切割 RNA 的 2.65Å 分辨率结构。一个首选的底物序列是绝对必需的,以使 RNA/DNA 杂交体能够采用适当的扭曲构象,与 RT 中的核糖核酸酶 H 活性部位相互作用。取代切割位点上游 4 个碱基的两个核苷酸会导致 4Å 的裂解磷酸位移。我们还确定了 HIV-1 RT 与核糖核酸酶 H 抗性多嘧啶片段序列的复合物结构,该序列采用刚性结构并容纳在核酸酶活性部位之外。基于这一新获得的结构信息和虚拟药物筛选,我们已经鉴定出一种针对病毒核糖核酸酶 H 的抑制剂,但对其细胞同源物没有作用。